Azitra (AZTR) Operating Expenses (2022 - 2026)
Azitra (AZTR) reported Operating Expenses of $3.9 million for Q1 2026, up 26.89% on a YoY basis from $3.1 million in Q1 2025, and up 76.68% quarter-over-quarter from $2.2 million in Q4 2025.
Azitra (AZTR) Operating Expenses (2022 - 2026) Analysis & Trends
Azitra has reported Operating Expenses for 5 years, with the latest figure at $3.9 million in Q1 2026.
- For the quarter ending Q1 2026, Operating Expenses rose 26.89% year-over-year to $3.9 million; the trailing twelve-month figure through Mar 2026 stood at $11.8 million (up 6.01% YoY), and the FY2025 full-year result was $11.0 million, changed 0.24% from the prior year.
- Operating Expenses for Q1 2026 stood at $3.9 million, up from $2.2 million in the prior quarter.
- The five-year high for Operating Expenses was $3.9 million in Q1 2026, with the low at $1.6 million in Q2 2023.
- Historically, Operating Expenses has averaged $2.6 million across 5 years, with a median of $2.6 million in 2023.
- Annual changes were most pronounced in 2023 — Operating Expenses decreased 26.4% — and 2024, when it surged 77.12%.
- Azitra's Operating Expenses stood at $2.7 million in 2022, then retreated by 6.16% to $2.6 million in 2023, then decreased by 4.93% to $2.4 million in 2024, then declined by 8.53% to $2.2 million in 2025, then surged by 76.68% to $3.9 million in 2026.
- The last three Operating Expenses figures came in at $3.9 million (Q1 2026), $2.2 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.33 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -138.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 574,669.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.85 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -67.40 Mn |
| 10 | Azitra | 20,900.00 | 20,900.00 | - | 3.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 2.23 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 2.87 Mn |
| Mar 31, 2025 | 3.10 Mn |
| Dec 31, 2024 | 2.43 Mn |
| Sep 30, 2024 | 2.93 Mn |
| Jun 30, 2024 | 2.67 Mn |
| Mar 31, 2024 | 2.96 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 2.30 Mn |
| Jun 30, 2023 | 1.60 Mn |
| Mar 31, 2023 | 1.67 Mn |
| Dec 31, 2022 | 2.73 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | 2.17 Mn |